sults demonstrated that the wild type strain, S. erythraea NRRL2338, can incorporate cyclopropane carboxylic acid and cyclobutane carboxylic acid to form novel erythromycins5). Based on these data, it was hypothesized that novel forms of 6-deoxy-erythromycin could be produced by feeding cyclopropane carboxylic acid to S. erythraea NRRL1 8643, a genetically-engineered strain with a knockout in the C-6 hydroxylase (eryF)6). This hypothesis was demonstrated experimentally.
Materials and Methods

Microorgani sm
Saccharopolyspora erythraea NRRL18643 was maintained as a 20% glycerol stock at -20°C.
Production of 6-Deoxy-13-cyclopropyl-erythromycin B
at Flask Scale S. erythraea NRRL18643 was plated onto 1/2YPD agar (Difco yeast extract 0.5%, Difco Bacto peptone 0.5%, dextrose 0.25%, MOPSbuffer 0.5%, Difco Bacto agar 1.7%, pH adjusted to 7.0 prior to autoclaving) and incubated at 28°C until grown (approximately 4 days). An agar plug (6 mmdiameter) was used to inoculate a 250 ml flask containing 25 ml of 1/2YPD broth (Difco yeast extract 0.5%, Difco Bacto peptone 0.5%, dextrose 0.25%, MOPSbuffer 0.5%, pHadjusted to 7.0prior to autoclaving). The culture was incubated on a rotary shaker at 29°C, 225rpm for 24hours. At this time, 2.5 ml of the first stage culture was inoculated into a 250 ml flask containing 25 ml ofEry-P medium (dextrose 5%, Nutrisoy flour 3%, (NH4)2SO4 0.3%, NaCl 0.5%, CaCO3 0.6%, pH adjusted to 7.0 prior to autoclaving) which was then incubated as above for a total of six days.
Cyclopropane carboxylic acid was added to the flasks at 24 and 48 hours to a final concentration of200 ppm at each ad- dition. After six days, whole broth was adjusted to pH 9.0 with NaOH.The fermentation was then extracted once with an equal volume ofethyl acetate. The organic phase was reduced to dryness under nitrogen (45°C bath). liters air/minute, 800 rpm, with pH controlled between 6.9 and 7.3 for 163 hours.
Isolation
After 163 hours, 16liters of whole broth from two fermentors was adjusted to pH 9.0 using NaOH. Broth was then extracted with an equal volume of ethyl acetate. The organic phase was concentrated using a rotary evaporator, then dissolved in 500 ml methylene chloride and extracted with an equal volume of pH 9.0 water. The methylene chloride phase was dried in vacuo, yielding 10grams of an oil. 
Results and Discussion
Structure Elucidation The isolated material was characterized as 6-deoxy-13-cyclopropyl-erythromycin B (4, Figure 2 ) by mass spectroscopy and NMR spectroscopy ( Table 1 ). The mass spectrum ( Figure 3 ) contained a base peak ofm/z 714.5, consistent with the proposed structure 4. In addition, the peak at m/z 556.4 is consistent with the loss of the neutral sugar cladinose, a commonfragment in the erythromycin series.
Also consistent with the proposed structure is the signal at m/z 158.3 which is characteristic of the basic sugar desosamine. High resolution MS (M+H+=714.4748) was consistent with the formula C38H67NOnto within 6 ppm. 2D NMRdetermined the line assignment described in Table 1 . The number of observed carbons, the respective number of attached protons and the inferred numberof oxygen, nitrogen and hydroxyl groups give rise to a calculated molecular formula of C38H67NOnwith a total mass consistent with the mass spectral data8). The two most pertinent assignments, i.e., the presence of a cyclopropyl group at the 13 position, and the absence of the hydroxyl group at the 6 position, are described in detail below. Table 2 .
Discussion
The incorporation of cyclopropane carboxylic acid to form 6-deoxy-1 3-cyclopropyl-erythromycin B (4) provides another example of the relaxed specificity of the DEBS starter unit in vivo. Previously, the loading domain of the wild type erythromycin producer has been shown to accept acetate to form low levels of 15-nor-erythromycin C3). Similar results were seen whenDEBSwas expressed in Streptomycescoelicolor9). These results are not surprising given the similarity to the propionate-derived erythromycin starter unit. The incorporation of a larger starter unit, butyryl CoA, to produce a novel triketide lactone has only been shown in an in vitro system2\ The formation of the novel 6-deoxy-erythromycin B derivative reported herein clearly demonstrates that the DEBSloading domain is relaxed with respect to larger starting units in vivo as well.
The novel macrolide had biological activity (Table 2) similar to 6-deoxy-erythromycin A, but was less effective than erythromycins A and B against some pathogens. 6-deoxy-13-cyclopropyl-erythromycin B was less active than erythromycins A and B ference maybe attributed to the lack of the C-6 hydroxyl group, rather than the novel C-13 cyelopropyl group.
